Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Medical Isotope Market, by Type
1.4.2 Asia Pacific Medical Isotope Market, by End User
1.4.3 Asia Pacific Medical Isotope Market, by Application
1.4.4 Asia Pacific Medical Isotope Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis
Chapter 4. Recent Strategies Deployed in Medical Isotopes Market
Chapter 5. Asia Pacific Medical Isotope Market by Type
5.1 Asia Pacific Radioisotopes Market by Country
5.2 Asia Pacific Stable Isotopes Market by Country
Chapter 6. Asia Pacific Medical Isotope Market by End User
6.1 Asia Pacific Hospitals Market by Country
6.2 Asia Pacific Diagnostic Centers Market by Country
6.3 Asia Pacific Research Institutes Market by Country
Chapter 7. Asia Pacific Medical Isotope Market by Application
7.1 Asia Pacific Diagonostic Market by Country
7.2 Asia Pacific Nuclear Therapy Market by Country
Chapter 8. Asia Pacific Medical Isotope Market by Country
8.1 China Medical Isotope Market
8.1.1 China Medical Isotope Market by Type
8.1.2 China Medical Isotope Market by End User
8.1.3 China Medical Isotope Market by Application
8.2 Japan Medical Isotope Market
8.2.1 Japan Medical Isotope Market by Type
8.2.2 Japan Medical Isotope Market by End User
8.2.3 Japan Medical Isotope Market by Application
8.3 India Medical Isotope Market
8.3.1 India Medical Isotope Market by Type
8.3.2 India Medical Isotope Market by End User
8.3.3 India Medical Isotope Market by Application
8.4 South Korea Medical Isotope Market
8.4.1 South Korea Medical Isotope Market by Type
8.4.2 South Korea Medical Isotope Market by End User
8.4.3 South Korea Medical Isotope Market by Application
8.5 Singapore Medical Isotope Market
8.5.1 Singapore Medical Isotope Market by Type
8.5.2 Singapore Medical Isotope Market by End User
8.5.3 Singapore Medical Isotope Market by Application
8.6 Malaysia Medical Isotope Market
8.6.1 Malaysia Medical Isotope Market by Type
8.6.2 Malaysia Medical Isotope Market by End User
8.6.3 Malaysia Medical Isotope Market by Application
8.7 Rest of Asia Pacific Medical Isotope Market
8.7.1 Rest of Asia Pacific Medical Isotope Market by Type
8.7.2 Rest of Asia Pacific Medical Isotope Market by End User
8.7.3 Rest of Asia Pacific Medical Isotope Market by Application
Chapter 9. Company Profiles
9.1 Canadian Nuclear Laboratories (Atomic Energy of Canada Limited)
9.1.1 Company Overview
9.1.2 Recent strategies and developments:
9.1.2.1 Partnerships, Collaborations, and Agreements:
9.1.3 SWOT Analysis
9.2 ITM Isotope Technologies Munich SE
9.2.1 Company Overview
9.2.2 Recent strategies and developments:
9.2.2.1 Partnerships, Collaborations, and Agreements:
9.2.3 SWOT Analysis
9.3 ECZACIBAŞI-MONROL
9.3.1 Company Overview
9.3.2 Recent strategies and developments:
9.3.2.1 Partnerships, Collaborations, and Agreements:
9.3.3 SWOT Analysis
9.4 NorthStar Medical Radioisotopes, LLC
9.4.1 Company Overview
9.4.2 Recent strategies and developments:
9.4.2.1 Partnerships, Collaborations, and Agreements:
9.4.3 SWOT Analysis
9.5 Iba SA
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expenses
9.5.5 SWOT Analysis
9.6 Mallinckrodt PLC
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 SWOT Analysis
9.7 GE HealthCare Technologies, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.6 SWOT Analysis
9.8 Nordion Inc. (Sotera Health LLC)
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.9 Bayer AG
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expense
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.6 SWOT Analysis
9.10. Siemens Healthineers AG (Siemens AG)
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expense
9.10.5 SWOT Analysis
Unique Offerings 